Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Noa Lavi

Showing results (31-40 of 58) with videos related to

Pageof 6
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 12, 2019
Baseline Chest Computed Tomography for Early Diagnosis of Invasive Pulmonary Aspergillosis in Hemato-oncological Patients: A Prospective Cohort StudyRoni Bitterman, Emilia Hardak, Marina Raines, et al.
Cancers|March 29, 2023
Venetoclax in Relapse/Refractory AL Amyloidosis-A Multicenter International Retrospective Real-World StudyEyal Lebel, Efstathios Kastritis, Giovanni Palladini, et al.
American Journal of Hematology|June 19, 2019
Characteristics, management and outcome of DLBCL patients, presenting with simultaneous systemic and CNS disease at diagnosis: A retrospective multicenter studyChava Perry, Sharon Ben Barouch, Neta Goldschmidt, et al.
American Journal of Hematology|April 1, 2018
Treatment patterns and clinical outcomes in high-risk newly diagnosed multiple myeloma patients carrying the 17p deletion: An observational multi-center retrospective studyYael C Cohen, Avi Saranga, Moshe E Gatt, et al.
Leukemia Research|September 15, 2015
Ruxolitinib treatment for myelofibrosis: Efficacy and tolerability in routine practiceMartin H Ellis, Noa Lavi, Elena Mishchenko, et al.
British Journal of Haematology|November 17, 2015
Efficacy and safety of salvage therapy using Carfilzomib for relapsed or refractory multiple myeloma patients: a multicentre retrospective observational studyEli Muchtar, Moshe E Gatt, Ory Rouvio, et al.
Molecular Cancer Research : MCR|August 15, 2019
Proinflammatory Macrophages Promote Multiple Myeloma Resistance to Bortezomib TherapyOfrat Beyar-Katz, Ksenia Magidey, Anat Reiner-Benaim, et al.
Leukemia & Lymphoma|April 4, 2019
Superior outcome of patients with favorable-risk acute myeloid leukemia using consolidation with autologous stem cell transplantationOfrat Beyar-Katz, Noa Lavi, Shimrit Ringelstein-Harlev, et al.
Annals of Hematology|December 11, 2024
In patients with follicular lymphoma, delayed-onset neutropenia induced by anti-CD20 monoclonal antibodies frequently occurs during maintenance therapy and is preferentially associated with obinutuzumabNashwa Fadaos, Yossi Ben Dor, Tehila Azoulay, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 7, 2020
Bortezomib Maintenance Therapy as a Standard of Care Provides Favorable Outcomes in Newly Diagnosed Myeloma Patients: A Multisite Real-Life StudyEfrat Luttwak, Moshe E Gatt, Eyal Lebel, et al.
Pageof 6

Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 12, 2019
Baseline Chest Computed Tomography for Early Diagnosis of Invasive Pulmonary Aspergillosis in Hemato-oncological Patients: A Prospective Cohort StudyRoni Bitterman, Emilia Hardak, Marina Raines, et al.
Cancers|March 29, 2023
Venetoclax in Relapse/Refractory AL Amyloidosis-A Multicenter International Retrospective Real-World StudyEyal Lebel, Efstathios Kastritis, Giovanni Palladini, et al.
American Journal of Hematology|June 19, 2019
Characteristics, management and outcome of DLBCL patients, presenting with simultaneous systemic and CNS disease at diagnosis: A retrospective multicenter studyChava Perry, Sharon Ben Barouch, Neta Goldschmidt, et al.
American Journal of Hematology|April 1, 2018
Treatment patterns and clinical outcomes in high-risk newly diagnosed multiple myeloma patients carrying the 17p deletion: An observational multi-center retrospective studyYael C Cohen, Avi Saranga, Moshe E Gatt, et al.
Leukemia Research|September 15, 2015
Ruxolitinib treatment for myelofibrosis: Efficacy and tolerability in routine practiceMartin H Ellis, Noa Lavi, Elena Mishchenko, et al.
British Journal of Haematology|November 17, 2015
Efficacy and safety of salvage therapy using Carfilzomib for relapsed or refractory multiple myeloma patients: a multicentre retrospective observational studyEli Muchtar, Moshe E Gatt, Ory Rouvio, et al.
Molecular Cancer Research : MCR|August 15, 2019
Proinflammatory Macrophages Promote Multiple Myeloma Resistance to Bortezomib TherapyOfrat Beyar-Katz, Ksenia Magidey, Anat Reiner-Benaim, et al.
Leukemia & Lymphoma|April 4, 2019
Superior outcome of patients with favorable-risk acute myeloid leukemia using consolidation with autologous stem cell transplantationOfrat Beyar-Katz, Noa Lavi, Shimrit Ringelstein-Harlev, et al.
Annals of Hematology|December 11, 2024
In patients with follicular lymphoma, delayed-onset neutropenia induced by anti-CD20 monoclonal antibodies frequently occurs during maintenance therapy and is preferentially associated with obinutuzumabNashwa Fadaos, Yossi Ben Dor, Tehila Azoulay, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 7, 2020
Bortezomib Maintenance Therapy as a Standard of Care Provides Favorable Outcomes in Newly Diagnosed Myeloma Patients: A Multisite Real-Life StudyEfrat Luttwak, Moshe E Gatt, Eyal Lebel, et al.
Pageof 6